Development of a new assay for the screening of hypochlorous acid scavengers based on reversed-phase high-performance liquid chromatography

被引:25
作者
Gatto, MT
Firuzi, O
Agostino, R
Grippa, E
Borsò, A
Spinelli, F
Pavan, L
Petrolati, M
Petrucci, R
Marrosu, G
Saso, L
机构
[1] Univ Roma La Sapienza, Dipartimento Farmacol Sostanze Nat & Fisiol Gen, I-00185 Rome, Italy
[2] Univ Roma La Sapienza, Dipartimento Ingn CMMPM, I-00161 Rome, Italy
关键词
D O I
10.1002/bmc.174
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
A new assay for the screening of hypochlorite/hypochlorous acid (XOCl) scavengers, based on the reversed-phase high performance liquid chromatographic analysis of human serum albumin (HSA, 0.2% in 100 ram sodium phosphate, pH 7), before and after oxidation by XOCl (1.6 mM), was developed. XOCl induced a significant decrease of the area under the chromatographic peak of HSA at 280 nm due to the oxidation of the aromatic amino acids tryptophan and tyrosine, as suggested by the literature and by the chromatographic analyses and the electrochemical study performed here. The assay was validated by testing known XOCl scavengers such as ascorbic acid, cysteine, glutathione, S-methylglutathione and alpha-lipoic acid and other antioxidants such as camosine and chlorogenic acid, which inhibited the oxidation of HSA. Quantitative activities were calculated using an original formula based on the changes of the area of the albumin peak. Electrochemical data collected here in a homogeneous medium showed that the anodic potentials of the antioxidants tested are less positive (ascorbic acid, chlorogenic acid and cysteine) or similar (alpha-lipoic acid) compared with those of the aromatic residues (tryptophan and tyrosine) of HSA oxidized by XOCL However, as expected, camosine, glutathione and S-methylglutathione were inactive at a glassy-carbon, gold or platinum electrode. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:404 / 411
页数:8
相关论文
共 25 条
[1]
Isoflavonoids and chronic disease: Mechanisms of action [J].
Barnes, S ;
Boersma, B ;
Patel, R ;
Kirk, M ;
Darley-Usmar, VM ;
Kim, H ;
Xu, J .
BIOFACTORS, 2000, 12 (1-4) :209-215
[2]
Bauerová K, 1999, GEN PHYSIOL BIOPHYS, V18, P15
[3]
A METHOD FOR SCREENING HYPOCHLOROUS ACID SCAVENGERS BY INHIBITION OF THE OXIDATION OF 5-THIO-2-NITROBENZOIC ACID - APPLICATION ANTIASTHMATIC DRUGS [J].
CHING, TL ;
DEJONG, J ;
BAST, A .
ANALYTICAL BIOCHEMISTRY, 1994, 218 (02) :377-381
[4]
Collins AR, 1999, BIOESSAYS, V21, P238, DOI 10.1002/(SICI)1521-1878(199903)21:3<238::AID-BIES8>3.0.CO
[5]
2-3
[6]
Mechanisms of disease - Antioxidants and atherosclerotic heart disease [J].
Diaz, MN ;
Frei, B ;
Vita, JA ;
Keaney, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :408-416
[7]
OXIDATIVE STRESS AND ITS CONTROL - A PATHOGENETIC ROLE IN INFLAMMATORY JOINT DISEASE [J].
FAIRBURN, K ;
STEVENS, CR ;
WINYARD, PG ;
KUS, M ;
WARD, RJ ;
CUNNINGHAM, J ;
ZAIDI, M ;
BLAKE, DR .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1993, 21 (02) :371-375
[8]
In vitro evaluation of antioxidant activity by electrophoresis and high performance liquid chromatography [J].
Grippa, E ;
Pavone, F ;
Gatto, MT ;
Petrucci, R ;
Marrosu, G ;
Silvestrini, B ;
Saso, L .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2000, 1524 (2-3) :171-177
[9]
SCAVENGING OF HYPOCHLOROUS ACID BY LIPOIC ACID [J].
HAENEN, GRMM ;
BAST, A .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 (11) :2244-2246
[10]
BIOLOGICALLY SIGNIFICANT SCAVENGING OF THE MYELOPEROXIDASE-DERIVED OXIDANT HYPOCHLOROUS ACID BY ASCORBIC-ACID - IMPLICATIONS FOR ANTIOXIDANT PROTECTION IN THE INFLAMED RHEUMATOID JOINT [J].
HALLIWELL, B ;
WASIL, M ;
GROOTVELD, M .
FEBS LETTERS, 1987, 213 (01) :15-17